Early clinical manifestations associated with death from visceral leishmaniasis.
about
Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysisVisceral leishmaniasis-associated mortality in Bangladesh: a retrospective cross-sectional study.Risk factors for seroconversion by Leishmania infantum in a cohort of dogs from an endemic area of Brazil.Mortality and case fatality due to visceral leishmaniasis in Brazil: a nationwide analysis of epidemiology, trends and spatial patterns.The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.Parasite load and risk factors for poor outcome among children with visceral leishmaniasis. A cohort study in Belo Horizonte, Brazil, 2010-2011.Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.Infection with Leishmania (Leishmania) infantum of 0 to 18-Month-old children living in a visceral leishmaniasis-endemic area in BrazilLeishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleenPrognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil.Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.Risk Factors for Death from Visceral Leishmaniasis in an Urban Area of Brazil.American visceral leishmaniasis: factors associated with lethality in the state of são paulo, Brazil.Late diagnosis: a factor associated with death from visceral leishmaniasis in elderly patients.Mortality from neglected tropical diseases in Brazil, 2000-2011.Human and canine visceral leishmaniasis in an emerging focus in Araçuaí, Minas Gerais: spatial distribution and socio-environmental factorsChallenges in the therapy of visceral leishmaniasis in Brazil: a public health perspective.Serological diagnosis of canine visceral leishmaniasis in Brazil: systematic review and meta-analysis.Visceral leishmaniasis in an environmentally protected area in southeastern Brazil: Epidemiological and laboratory cross-sectional investigation of phlebotomine fauna, wild hosts and canine cases.TNF signalling drives expansion of bone marrow CD4+ T cells responsible for HSC exhaustion in experimental visceral leishmaniasis.Leishmania infantum: illness, transmission profile and risk factors for asymptomatic infection in an endemic metropolis in Brazil.High visceral leishmaniasis mortality rate in Barra Mansa, a new area of visceral leishmaniasis transmission in the State of Rio de Janeiro, Brazil.Risk factors for mortality of children with zoonotic visceral leishmaniasis in Central Tunisia.Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?Is visceral leishmaniasis a sepsis or not?The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
P2860
Q27024638-39879157-43B7-463A-8FAD-7647F543ED9DQ30837994-EC07309F-C91E-4CB8-B1CC-2B84E4F03303Q31131843-91A4EFEA-6E9B-422B-9249-F0614EF7E28CQ31156309-84AF013E-55A9-4F88-8FE9-F6E5A46B64F8Q33429539-DAF9237D-D8B2-44FA-BEB5-B2E38CC93172Q33587103-FC273C24-B3F5-4F69-9356-811120613C5CQ33764787-F7C4CCB4-FF68-4A9D-9F56-70BC3EEE3F44Q34015949-6E5E0B97-9C72-44C9-B4EF-9CB14EB241B9Q34637852-988641AF-BDB7-41BC-86F1-9977332C8A59Q34680924-8ABB3C92-DEEE-420D-9406-3F878EECC3B8Q35151864-A1048ECF-DAAD-43D6-A006-52091F9C94C4Q35746358-56AB43D0-30EC-4C18-8A9B-F55EAC61F6A4Q36253633-11D07955-D2FF-4475-B5C2-7C18EE6D3E2CQ36504391-340922B8-4E03-4414-AFD3-9D435DB85067Q36570990-11B6C0EB-6B15-4C2E-B82B-3EF87DACD0ABQ37167721-A2CE8C41-C8C2-4C5E-9B84-84EA063A6B60Q38175140-568B023F-5576-4443-BEEE-563B6B7328C2Q38268806-E2A8EE08-7E89-4BA2-8E05-3E34949EB6FAQ40124182-EAC22BA7-E83B-46BB-AB76-4A36157F919FQ40149218-13411349-2E10-4695-ACD6-E66BC47F5CA3Q40432786-FAD7ED60-C93E-4926-BE5E-B31B7778EEBDQ41736225-94A4AFE6-F9D5-44D8-BB25-BA810B5D93BCQ47183269-B575C38B-0F29-422A-A7C1-B15E303FCB18Q54219659-C0C72835-4B5E-445B-A168-DCB8BD36EDD5Q55275631-35A85D25-BB2A-455D-92BF-8484A6CA74D9Q55482423-4BB3D940-02BB-4D2B-A87E-D32A44FD6FE4
P2860
Early clinical manifestations associated with death from visceral leishmaniasis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Early clinical manifestations associated with death from visceral leishmaniasis.
@ast
Early clinical manifestations associated with death from visceral leishmaniasis.
@en
Early clinical manifestations associated with death from visceral leishmaniasis.
@nl
type
label
Early clinical manifestations associated with death from visceral leishmaniasis.
@ast
Early clinical manifestations associated with death from visceral leishmaniasis.
@en
Early clinical manifestations associated with death from visceral leishmaniasis.
@nl
prefLabel
Early clinical manifestations associated with death from visceral leishmaniasis.
@ast
Early clinical manifestations associated with death from visceral leishmaniasis.
@en
Early clinical manifestations associated with death from visceral leishmaniasis.
@nl
P2093
P2860
P1476
Early clinical manifestations associated with death from visceral leishmaniasis
@en
P2093
Ana Rabello
Maria Helena Franco Morais
Mariângela Carneiro
Valdelaine Etelvina Miranda de Araújo
P2860
P356
10.1371/JOURNAL.PNTD.0001511
P407
P50
P577
2012-02-07T00:00:00Z